Susan Hasty, Publisher
Table of Contents . . . December 16th, 2002
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Hepatitis Weekly | Other Publications
Chronic Hepatitis C - Fractionated particles reveal complexity of hepatitis C virus infection
Liver Failure - Lamivudine too little, too late for chronic hepatitis B flare
Hepatitis B Therapy - Synthetic ribozymes a potential treatment for hepatitis B virus
Kidney Transplantation - Hepatitis C-positive kidneys increase mortality risk
Liver Transplantation - Several factors confound survival odds in liver cancer transplant recipients
Appointments - Susan Scher, MD, named VP of small-molecule drug manufacturer
Chronic Hepatitis B - Investigational new drug application submitted for Hepavir B
Chronic Hepatitis C - New noninvasive liver fibrosis test launched
Drug Resistance - Study evaluates performance of INNO-LiPA HBV DR assay
Drug Safety - Nanofiltration removes viruses from human immunoglobulin manufacturing process
Finance - Laboratory Corp. of America announces third quarter results
HCV Immunotherapy - Recombinant antibody Fab blocks HCV adsorption to susceptible cells in vitro
Hepatitis B Therapy - Beta-L-Fd4C inhibits both wild-type, lamivudine-resistant HBV
Hepatitis B Therapy - Lamivudine doesn't increase interferon efficacy in mutant type hepatitis B
Hepatitis C Therapy - Once-a-week dose of PegIntron may not be enough
Hepatitis C Therapy - Viramidine to advance to phase II clinical trials
Nonalcoholic Steatohepatitis - Murine leptin deficiency alters Kupffer cell production of regulatory cytokines
RNA Research - FDA Approves Versant HCV RNA qualitative assay
Transfusion Medicine - HBsAg false positive rates high in patients receiving fresh-frozen plasma
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.